QR-koodi

Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.

Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile characteristics, ddI must be administered with a buffe...

Täydet tiedot

Tallennettuna:
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Li, R C, Narang, P K, Sahai, J, Cameron, W, Bianchine, J R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 1997
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163960/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9210686/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.7.1566
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia